Agentix Quick Ratio (FWDR) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Agentix Corp   (FWDR)

Agentix 's Quick Ratio

FWDR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




Within Biotechnology & Pharmaceuticals industry Agentix Corp booked the highest Quick Ratio than Agentix in the first quarter 2026. While total ranking remained the same in the Q1 2026 compared to the fourth quarter 2026 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents FWDR´s has?
What are FWDR´s Current Liabilities?




FWDR Quick Ratio (Jun 30 2026)
Q1
(Mar 31 2026)
Q4
(Dec 31 2025)
Q3
(Sep 30 2025)
Q2
(Jun 30 2025)
Q1
Y / Y Current Liabilities Change 13.36 % 12.23 % 20.17 % -72.68 % 13.25 %
Y / Y Cash & cash equivalent Change - - - - -
Quick Ratio MRQ - 0 - - -
FWDR's Total Ranking # # # # #
Seq. Current Liabilities Change 3.27 % 12.23 % 290.15 % -74.93 % 2.24 %
Seq. Cash & cash equivalent Change - - - - -



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Agentix 's Current Liabilities $ 4 Millions Visit FWDR's Balance sheet
Agentix 's Cash & cash equivalent $ 0 Millions Visit FWDR's Balance sheet
Source of FWDR's Sales Visit FWDR's Sales by Geography


Cumulative Agentix 's Quick Ratio

FWDR's Quick Ratio for the trailling 12 Months

FWDR Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -6.73 % -7.41 % -6.47 % -10 % 8.33 %
Y / Y Cash & cash equivalent TTM Growth - - - - -
Quick Ratio TTM 0 0 - - -
Total Ranking TTM # 4877 # 0
Seq. Current Liabilities TTM Growth 4.02 % 3.73 % 5.4 % -17.98 % 3.26 %
Seq. Cash & cash equivalent TTM Growth 0 % - - - -


On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q1 2026 to $3.71 millions, cumulative Quick Ratio